Simvastatin-Loaded Lipid Emulsion Nanoparticles: Characterizations and Applications

Area of Science:

• Pharmacology
• Nanotechnology
• Drug Delivery Systems

Background:

• Simvastatin (SIM) is used to treat high blood lipid levels but suffers from significant gastrointestinal tract (GIT) metabolism with oral administration.
• This metabolism limits its therapeutic efficacy and necessitates alternative delivery strategies.

Purpose of the Study:

• To design and characterize a biodegradable nanocarrier system for simvastatin (SIM) to enhance its therapeutic role and bypass GIT metabolism.
• To evaluate the potential of SIM-loaded lipid emulsion nanoparticles (LENPs) for transdermal delivery.

Main Methods:

• SIM-loaded LENPs were prepared using a solvent injection method with cholesterol as the lipid core and Tween 80 as a stabilizer.
• Nanoformulations were characterized for particle size, zeta potential, surface morphology, entrapment efficiency, crystallinity, and molecular interactions.
• Transdermal hydrogels containing LENPs were assessed for physical properties, rheology, pH, and spreadability. In vitro transdermal assays were performed.

Main Results:

• The optimized SIM-loaded LENPs exhibited a mean particle size of 174 nm and a zeta potential of -22.5 mV.
• Crystallinity and Fourier transform infrared analyses indicated no significant molecular interactions between SIM and the carrier components.
• In vitro studies demonstrated sustained release from hydrogels compared to free SIM-loaded LENPs, suggesting potential for transdermal delivery.

Conclusions:

• Biodegradable SIM-loaded LENPs offer a promising alternative delivery system to overcome the limitations of oral simvastatin administration.
• Further in vivo studies are recommended to validate the transdermal delivery potential of these nanoformulations.